Research map: Anti-RBD Single-Chain Variable Fragments Library (scFv Library) Generation toward the Development of a Diagnostic Platform for SARS-CoV-2

Back to the article

Papers in this map

  1. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor · Jun Lan · 2020 · 6772 citations · Cited by this paper
  2. Recent Advances in Anti-Infective Drug Discovery from China · 2026 · Related
  3. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization · Delphine Planas · 2021 · 2192 citations · Cited by this paper
  4. Antimicrobial Peptides and Biofilms: From Molecular Interactions to Therapeutic Control · 2026 · Related
  5. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies · Yunlong Cao · 2021 · 2148 citations · Cited by this paper
  6. Strathclyde Minor Groove Binders Bearing Amidine Tail Groups are Effective against Gram-Positive Bacterial Pathogens · 2026 · Related
  7. Site-specific glycan analysis of the SARS-CoV-2 spike · Yasunori Watanabe · 2020 · 1724 citations · Cited by this paper
  8. Candida albicans RLM1 Diversity Regulates Cell Wall Composition and Virulence · 2026 · Related
  9. Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail · Johanna K. Hansen · 2020 · 1436 citations · Cited by this paper
  10. Minimum Inoculum of Resistance Assay for Evaluating Antitoxoplasmosis Compounds That Target Phenylalanine tRNA Synthetase · 2026 · Related
  11. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis · Xavier Brochet · 2008 · 1284 citations · Cited by this paper
  12. Issue Publication Information · 2026 · Related
  13. Molecular Architecture of the SARS-CoV-2 Virus · Hangping Yao · 2020 · 1128 citations · Cited by this paper
  14. When Second Messenger Signaling Meets Resistance: (p)ppGpp, C-di-GMP and C-di-AMP as Masters of Antibiotic Stress Adaptation · 2026 · Related
  15. Convalescent plasma as a potential therapy for COVID-19 · Long Chen · 2020 · 1094 citations · Cited by this paper
  16. Metabolic Screening of Gut Microbiota by Fourier-Transform Infrared Spectroscopy · 2026 · Related
  17. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum · Chang Liu · 2021 · 751 citations · Cited by this paper
  18. Platanosides, a Promising Class of Plant-Derived Antibiotics, Are Effective against a Suite of Clinically Derived MDR and Drug-Sensitive Staph and Strep spp. · 2026 · Related
  19. The HADDOCK2.4 web server for integrative modeling of biomolecular complexes · Rodrigo V. Honorato · 2024 · 619 citations · Cited by this paper
  20. Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody Response · 2024 · Related
  21. Structural biology of SARS-CoV-2 and implications for therapeutic development · Haitao Yang · 2021 · 586 citations · Cited by this paper
  22. The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates · Bryan E. Jones · 2021 · 504 citations · Cited by this paper
  23. Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China · Mingxiang Ye · 2020 · 432 citations · Cited by this paper
  24. IMGT/V-QUEST: IMGT Standardized Analysis of the Immunoglobulin (IG) and T Cell Receptor (TR) Nucleotide Sequences · Véronique Giudicelli · 2011 · 399 citations · Cited by this paper
  25. SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies · MacGregor Cox · 2022 · 376 citations · Cited by this paper
  26. Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions · Yingjie Wang · 2020 · 365 citations · Cited by this paper
  27. Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 · Emi Takashita · 2022 · 293 citations · Cited by this paper
  28. Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB · Masaki Imai · 2022 · 290 citations · Cited by this paper
  29. The glycosylation in SARS-CoV-2 and its receptor ACE2 · Yanqiu Gong · 2021 · 230 citations · Cited by this paper
  30. Phage Display Libraries for Antibody Therapeutic Discovery and Development · Juan Carlos Almagro · 2019 · 174 citations · Cited by this paper
  31. Development of a SARS-CoV-2-specific biosensor for antigen detection using scFv-Fc fusion proteins · Hye-Yeon Kim · 2020 · 144 citations · Cited by this paper
  32. Structural and antigenic variations in the spike protein of emerging SARS-CoV-2 variants · Anshumali Mittal · 2022 · 136 citations · Cited by this paper
  33. Structural and functional comparison of SARS-CoV-2-spike receptor binding domain produced in Pichia pastoris and mammalian cells · Claudia R. Arbeitman · 2020 · 131 citations · Cited by this paper
  34. A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations · Federico Bertoglio · 2021 · 110 citations · Cited by this paper
  35. Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries · Peter Amersdorfer · 1997 · 105 citations · Cited by this paper
  36. Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern · Marco Falcone · 2021 · 89 citations · Cited by this paper
  37. Significant Differences in Physicochemical Properties of Human Immunoglobulin Kappa and Lambda CDR3 Regions · Catherine L. Townsend · 2016 · 87 citations · Cited by this paper
  38. Glycosylation of the viral attachment protein of avian coronavirus is essential for host cell and receptor binding · Lisa M. Parsons · 2019 · 82 citations · Cited by this paper
  39. A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy · Allison J. Greaney · 2022 · 81 citations · Cited by this paper

Source: OpenAlex (CC0)